Evidence map›Paper›PMID 40309436›Full record

Trial reportFrontiers in endocrinology2025

Preliminary effects and feasibility of online interactive Baduanjin exercise in adults with overweight and obesity: a pilot randomized controlled trial.

Yan Yu, Jinpeng Wu, Tongtong Wu, Genghang Chen, Xueyin Chen, Shaonan Liu, Yu Chen, Lihong Yang, Xinfeng Guo

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yan Yu *Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jinpeng Wu *Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Tongtong WuSecond Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Genghang ChenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Xueyin ChenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Shaonan LiuThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Yu ChenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Lihong YangThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.
Xinfeng GuoThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Overweight and obesity are chronic conditions with severe health implications, demanding effective and sustainable management strategies. The escalated Baduanjin, an adapted form of traditional Baduanjin, is proposed as a targeted intervention for individuals with overweight and obesity, offering a potentially effective and accessible approach to weight management and overall health improvement. Objectives: This pilot study aimed to assess the preliminary effects and feasibility of the online interactive escalated Baduanjin exercise program, with a focus on participant engagement and acceptance. Methods: A 12-week pilot randomized controlled trial was conducted in Guangzhou, China, from June 30 to November 15, 2023, involving 50 participants with overweight and obesity. Participants were randomly allocated to the intervention group (n=26) or the control group (n=24). The intervention group received three 60-minute online interactive escalated Baduanjin exercises per week for 12 weeks, in addition to health education. The control group received only health education, delivered in three sessions over the 12-week period. The primary outcome was the change in body mass index (BMI) from baseline to week 12. Secondary outcomes included changes in waist circumference, body weight, blood glucose, lipid levels, blood pressure, quality of life, and dampness scale scores. Feasibility was assessed by participant adherence to the required intervention, and adverse events were recorded throughout the study period. Results: Compared to the control group, the intervention group exhibited a reduction in BMI (mean ± SD: -0.54 ± 1.67 vs. -0.13 ± 0.81), body weight, diastolic blood pressure, fasting blood glucose, and triglyceride levels over the 12 weeks, though this difference was not statistically significant. However, the intervention group demonstrated significant improvements in several health parameters, including waist circumference, fatigue scale-14 (FS-14), general anxiety disorder (GAD-7), patient health questionnaire-9 items (PHQ-9), Pittsburgh sleep quality index (PSQI), and dampness scale scores. Adherence to the intervention was high, with 82% (41/50) of participants completing the trial, and no serious adverse events were reported. Conclusion: The preliminary effects and feasibility of the online interactive escalated Baduanjin for adults with overweight and obesity have been demonstrated, highlighting its potential multifaceted health benefits and high adherence. Clinical Trial Registration: https://www.chictr.org.cn, identifier ChiCTR2300072981.

Indexed as

ExerciseExercise TherapyObesityOverweightQigongAdultBody Mass IndexChinaFeasibility StudiesFemaleHumansMaleMiddle AgedPilot ProjectsQuality of LifeBaduanjinobesityoverweightpilot studyrandomized controlled trial

Identifiers

PMID40309436
PMCPMC12040658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.